AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 71 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,005,369 | -20.9% | 3,758,686 | 0.0% | 3.22% | -23.8% |
| Q2 2023 | $64,461,465 | -15.0% | 3,758,686 | 0.0% | 4.22% | -12.9% |
| Q1 2023 | $75,812,697 | -31.2% | 3,758,686 | 0.0% | 4.85% | -25.8% |
| Q4 2022 | $110,129,500 | +76.7% | 3,758,686 | 0.0% | 6.54% | +80.2% |
| Q3 2022 | $62,319,000 | +6.1% | 3,758,686 | 0.0% | 3.63% | -25.9% |
| Q2 2022 | $58,748,000 | -14.7% | 3,758,686 | 0.0% | 4.89% | -6.4% |
| Q1 2022 | $68,897,000 | +55.5% | 3,758,686 | 0.0% | 5.23% | +102.0% |
| Q4 2021 | $44,315,000 | -43.8% | 3,758,686 | 0.0% | 2.59% | -44.6% |
| Q3 2021 | $78,857,000 | -8.1% | 3,758,686 | 0.0% | 4.67% | -5.6% |
| Q2 2021 | $85,811,000 | – | 3,758,686 | – | 4.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |